Provide feedbackProvide feedback

Home :: Pediatrics

SK Biopharmaceuticals' carisbamate granted orphan drug status for treating infantile spasms

Friday, April 20 2012 | Comments
Evidence Grade 0 What's This?

SK Biopharmaceuticals Co. Ltd.'s carisbamate, a chlorophenyl carbamate, received an orphan drug designation from the Food and Drug Administration for the management of infantile spasms, a form of epilepsy that is associated with increased risk for death or mental retardation. Carisbamate, one of the key products in the firm's central nervous system development pipeline, has demonstrated efficacy in clinical trials for adult forms of epilepsy, such as partial-onset seizures, according to...

SK Biopharmaceuticals Co. Ltd.'s carisbamate, a chlorophenyl carbamate, received an orphan drug designation from the Food and Drug Administration for the management of infantile spasms, a form of epilepsy that is associated with increased risk for death or mental retardation.

Carisbamate, one of the key products in the firm's central nervous system development pipeline, has demonstrated efficacy in clinical trials for adult forms of epilepsy, such as partial-onset seizures, according to SK Biopharmaceuticals. The company said the exact mechanism of action of the drug's therapeutic benefit has not yet been defined.

SK Biopharmaceuticals noted that the onset of infantile spasms generally occurs during the first year of life and they usually stop by the time the child reaches 5 years of age but may be replaced by other types of seizures. Infantile spasms are the major cause of cognitive deterioration in the first year of life, the firm added.

Latest News

FDA issues warning about accidental exposure to fentanyl pain patch among young children Verusmed

Friday, April 20 2012 | Comments
Evidence Grade 0 What's This?

The Food and Drug Administration issued a public safety alert to warn that young children could die or become seriously ill if exposed to the fentanyl transdermal system, which Janssen Pharmaceuticals Inc. markets under the brand name Duragesic and is available in generic formulations.

The agency said there have been 26 cases of accidental exposure to fentanyl...



Several racial/ethnic disparities in health, health care reported among adolescents, data reveal Verusmed

Saturday, April 07 2012 | Comments
Evidence Grade 0 What's This?

Multiple racial/ethnic disparities in health and health care exist among adolescents aged 10 to 17 years, new research shows.

The study investigators noted that adolescents in this age group represent nearly half of the pediatric population in the United States and approximately half are considered racial/ethnic minorities. 

Data for the analysis were obtained from the 2003 National Survey of Children's Health, a cross-sectional, random-digit-dial...



Raptor submits NDA for delayed-release formulation of cysteamine bitartrate as treatment for nephropathic cystinosis Verusmed

Monday, April 02 2012 | Comments
Evidence Grade 0 What's This?

Raptor Pharmaceutical Corp. submitted a New Drug Application (NDA) to the Food and Drug Administration for RP103, a delayed-release capsule formulation of cysteamine bitartrate, seeking approval of the drug as a treatment for nephropathic cystinosis.

The company requested priority review status for the NDA. If granted, the FDA could render a decision on the application...



AVI BioPharma's eteplirsen meets primary endpoint of midstage trial in Duchenne muscular dystrophy but fails to improve clinical outcomes; shares drop Verusmed

Monday, April 02 2012 | Comments
Evidence Grade 0 What's This?

Although AVI BioPharma Inc.'s eteplirsen, an investigational treatment for Duchenne muscular dystrophy (DMD) and AVI BioPharma's lead drug candidate, met the primary endpoint of a small midstage study, news that the drug failed to improve clinical outcomes sent the firm's shares down 27.9 percent.

The double-blind Phase IIb trial, known as Study 201, included 12 boys...





Pediatrics Conference Coverage
  1. No articles have been read
  1. No articles have been emailed
Videos